Literature DB >> 11176865

Prospects for neurology and psychiatry.

W M Cowan1, E R Kandel.   

Abstract

Neurological and psychiatric illnesses are among the most common and most serious health problems in developed societies. The most promising advances in neurological and psychiatric diseases will require advances in neuroscience for their elucidation, prevention, and treatment. Technical advances have improved methods for identifying brain regions involved during various types of cognitive activity, for tracing connections between parts of the brain, for visualizing individual neurons in living brain preparations, for recording the activities of neurons, and for studying the activity of single-ion channels and the receptors for various neurotransmitters. The most significant advances in the past 20 years have come from the application to the nervous system of molecular genetics and molecular cell biology. Discovery of the monogenic disorder responsible for Huntington disease and understanding its pathogenesis can serve as a paradigm for unraveling the much more complex, polygenic disorders responsible for such psychiatric diseases as schizophrenia, manic depressive illness, and borderline personality disorder. Thus, a new degree of cooperation between neurology and psychiatry is likely to result, especially for the treatment of patients with illnesses such as autism, mental retardation, cognitive disorders associated with Alzheimer and Parkinson disease that overlap between the 2 disciplines.

Entities:  

Mesh:

Year:  2001        PMID: 11176865     DOI: 10.1001/jama.285.5.594

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

1.  Neurodegenerative disorders.

Authors:  R Kale
Journal:  BMJ       Date:  2001-10-20

Review 2.  Neurogenetics: single gene disorders.

Authors:  S-M Pulst
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

3.  [The relationship between psychiatry and neurology].

Authors:  W H Oertel; T T J Kircher
Journal:  Nervenarzt       Date:  2010-11       Impact factor: 1.214

4.  Studies of damage to hippocampal neurons in inbred mouse lines in models of epilepsy using kainic acid and pilocarpine.

Authors:  N P Shikhanov; N M Ivanov; A V Khovryakov; K Kaspersen; G M McCann; P P Kruglyakov; A A Sosunov
Journal:  Neurosci Behav Physiol       Date:  2005-07

5.  Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome.

Authors:  Eva W C Chow; Robert B Zipursky; David J Mikulis; Anne S Bassett
Journal:  Biol Psychiatry       Date:  2002-02-01       Impact factor: 13.382

Review 6.  Schizophrenia and genetics: new insights.

Authors:  Anne S Bassett; Eva W Chow; Rosanna Weksberg; Linda Brzustowicz
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

7.  Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits.

Authors:  Jorge J Palop; Brian Jones; Lisa Kekonius; Jeannie Chin; Gui-Qiu Yu; Jacob Raber; Eliezer Masliah; Lennart Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

8.  Is shared learning the way to bring UK neurology and psychiatry closer: what teachers, trainers and trainees think.

Authors:  F Schon; A MacKay; C Fernandez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

9.  Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease.

Authors:  Diêgo Madureira de Oliveria; George Barreto; Deyse Valverde G De Andrade; Ezequiel Saraceno; Laura Aon-Bertolino; Francisco Capani; Ramon Dos Santos El Bachá; Lisandro Diego Giraldez
Journal:  Neurochem Res       Date:  2008-05-30       Impact factor: 3.996

Review 10.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.